Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas Long Term Debt 2010-2023 | HYPMY

Hypermarcas long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
  
Hypermarcas Annual Long Term Debt
(Millions of US $)
2022 $1,430
2021 $1,261
2020 $980
2019 $328
2018 $125
2017 $100
2016 $196
2015 $1,269
2014 $1,317
2013 $1,481
2012 $1,932
2011 $2,645
2010 $1,757
2009 $674
Hypermarcas Quarterly Long Term Debt
(Millions of US $)
2023-09-30 $1,645
2023-06-30 $1,633
2023-03-31 $1,465
2022-12-31 $1,430
2022-09-30 $1,414
2022-06-30 $1,357
2022-03-31 $1,257
2021-12-31 $1,261
2021-09-30 $1,248
2021-06-30 $1,046
2021-03-31 $1,092
2020-12-31 $980
2020-09-30 $962
2020-06-30 $776
2020-03-31 $317
2019-12-31 $328
2019-09-30 $108
2019-06-30 $111
2019-03-31 $119
2018-12-31 $125
2018-09-30 $100
2018-06-30 $85
2018-03-31 $96
2017-12-31 $100
2017-09-30 $100
2017-06-30 $99
2017-03-31 $116
2016-12-31 $196
2016-09-30 $341
2016-06-30 $407
2016-03-31 $332
2015-12-31 $1,269
2015-09-30 $1,115
2015-06-30 $1,147
2015-03-31 $1,095
2014-12-31 $1,317
2014-09-30 $1,590
2014-06-30 $1,703
2014-03-31 $1,469
2013-12-31 $1,481
2013-09-30 $1,650
2013-06-30 $1,606
2013-03-31 $1,724
2012-12-31 $1,932
2012-09-30 $2,083
2012-06-30 $2,145
2012-03-31 $2,319
2011-12-31 $2,645
2011-09-30 $2,877
2011-06-30 $2,736
2011-03-31 $2,118
2010-12-31 $1,757
2010-09-30 $1,410
2010-06-30 $1,031
2010-03-31 $907
2009-12-31 $674
2009-09-30 $402
2009-06-30 $255
2009-03-31 $370
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $1.585B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $70.026B 28.78
Chugai Pharmaceutical (CHGCY) Japan $53.561B 23.26
Takeda Pharmaceutical (TAK) Japan $41.649B 6.75
Merck (MKGAF) Germany $20.517B 19.36
Astellas Pharma (ALPMY) Japan $17.138B 24.28
Shionogi (SGIOY) Japan $14.066B 12.17
Sandoz Group AG (SDZNY) Switzerland $13.508B 0.00
Neurocrine Biosciences (NBIX) United States $13.189B 54.77
United Therapeutics (UTHR) United States $11.150B 11.94
Catalent (CTLT) United States $10.098B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.652B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.884B 6.98
Ionis Pharmaceuticals (IONS) United States $5.948B 0.00
Revolution Medicines (RVMD) United States $5.901B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.422B 0.00
Alpine Immune Sciences (ALPN) United States $4.223B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.994B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.801B 0.00
Indivior (INDV) United States $2.587B 12.03
Evotec AG (EVO) Germany $2.534B 0.00
Summit Therapeutics (SMMT) United States $2.463B 0.00
Corcept Therapeutics (CORT) United States $2.346B 23.85
Dyne Therapeutics (DYN) United States $2.038B 0.00
PTC Therapeutics (PTCT) United States $1.891B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.810B 18.71
Fusion Pharmaceuticals (FUSN) Canada $1.803B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.736B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.735B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.646B 9.75
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Avadel Pharmaceuticals (AVDL) Ireland $1.574B 0.00
Ardelyx (ARDX) United States $1.499B 0.00
4D Molecular Therapeutics (FDMT) United States $1.268B 0.00
Pacira BioSciences (PCRX) United States $1.214B 12.08
Soleno Therapeutics (SLNO) United States $1.206B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.190B 11.18
Xencor (XNCR) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.137B 7.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.056B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.928B 0.00
Cronos Group (CRON) Canada $0.921B 0.00
Cassava Sciences (SAVA) United States $0.916B 0.00
Ocular Therapeutix (OCUL) United States $0.871B 0.00
USANA Health Sciences (USNA) United States $0.836B 13.17
Enliven Therapeutics (ELVN) United States $0.827B 0.00
ARS Pharmaceuticals (SPRY) United States $0.814B 0.00
Relay Therapeutics (RLAY) United States $0.802B 0.00
Sage Therapeutics (SAGE) United States $0.783B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.696B 0.00
Savara (SVRA) United States $0.662B 0.00
Silence Therapeutics (SLN) United Kingdom $0.659B 0.00
Lyell Immunopharma (LYEL) United States $0.592B 0.00
Siga Technologies (SIGA) United States $0.585B 8.66
Verve Therapeutics (VERV) United States $0.557B 0.00
ProKidney (PROK) United States $0.550B 0.00
OmniAb (OABI) United States $0.538B 0.00
Korro Bio (KRRO) United States $0.536B 0.00
Exscientia (EXAI) United Kingdom $0.527B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.526B 0.00
Altimmune (ALT) United States $0.488B 0.00
KalVista Pharmaceuticals (KALV) United States $0.485B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.447B 0.00
Heron Therapeutics (HRTX) United States $0.407B 0.00
Larimar Therapeutics (LRMR) United States $0.407B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Lexeo Therapeutics (LXEO) United States $0.398B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.384B 0.00
Harrow (HROW) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.377B 71.50
Bioventus (BVS) United States $0.360B 0.00
Esperion Therapeutics (ESPR) United States $0.354B 0.00
Nature's Sunshine Products (NATR) United States $0.352B 19.68
Aquestive Therapeutics (AQST) United States $0.330B 0.00
Lyra Therapeutics (LYRA) United States $0.322B 0.00
Fractyl Health (GUTS) United States $0.315B 0.00
ESSA Pharma (EPIX) Canada $0.297B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.293B 0.00
Akebia Therapeutics (AKBA) United States $0.291B 0.00
Metagenomi (MGX) United States $0.290B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.280B 0.00
Black Diamond Therapeutics (BDTX) United States $0.274B 0.00
Pyxis Oncology (PYXS) United States $0.263B 0.00
Adherex Technologies (FENC) United States $0.259B 0.00
Nanobiotix S.A (NBTX) France $0.259B 0.00
Xeris Biopharma Holdings (XERS) United States $0.247B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Acrivon Therapeutics (ACRV) United States $0.239B 0.00
Telomir Pharmaceuticals (TELO) United States $0.235B 0.00
Foghorn Therapeutics (FHTX) United States $0.235B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Avita Medical (RCEL) United States $0.228B 0.00
Conduit Pharmaceuticals (CDT) United States $0.218B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Zevra Therapeutics (ZVRA) United States $0.195B 0.00
Century Therapeutics (IPSC) United States $0.193B 0.00
Profound Medical (PROF) Canada $0.192B 0.00
Prelude Therapeutics (PRLD) United States $0.189B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.184B 0.00
MediWound (MDWD) Israel $0.161B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Incannex Healthcare (IXHL) Australia $0.151B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
VAXART, INC (VXRT) United States $0.146B 0.00
Regulus Therapeutics (RGLS) United States $0.145B 0.00
Elite Pharmaceuticals (ELTP) United States $0.143B 13.35
GlycoMimetics (GLYC) United States $0.139B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.134B 2.83
Relmada Therapeutics (RLMD) United States $0.130B 0.00
Citius Pharmaceuticals (CTXR) United States $0.128B 0.00
Inotiv (NOTV) United States $0.121B 0.00
Eliem Therapeutics (ELYM) United States $0.116B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.114B 0.00
OptiNose (OPTN) United States $0.105B 0.00
Vivani Medical (VANI) United States $0.099B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
AlloVir (ALVR) United States $0.085B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.072B 5.80
Journey Medical (DERM) United States $0.071B 0.00
Carisma Therapeutics (CARM) United States $0.071B 0.00
Tempest Therapeutics (TPST) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) $0.060B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.053B 0.79
BioLineRx (BLRX) Israel $0.051B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.049B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Unicycive Therapeutics (UNCY) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Viracta Therapeutics (VIRX) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.032B 0.00
JanOne (JAN) United States $0.032B 0.00
Nutriband (NTRB) United States $0.032B 0.00
Protara Therapeutics (TARA) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Lipocine (LPCN) United States $0.029B 0.00
NRx Pharmaceuticals (NRXP) United States $0.029B 0.00
DURECT (DRRX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 11.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
CERo Therapeutics Holdings (CERO) United States $0.023B 0.00
Addex Therapeutics (ADXN) Switzerland $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.09
Indaptus Therapeutics (INDP) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Surrozen (SRZN) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Talphera (TLPH) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Biomerica (BMRA) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.010B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.19
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 45.81